Bellerophon Therapeutics Competitors and Similar CompaniesClear all

Bellerophon Therapeutics's competitors and similar companies include Salarius Pharmaceuticals, UNITY Biotechnology and Synthorx.

	Bellerophon Therapeutics Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.	Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.	UNITY Biotechnology Unity Biotechnology designs therapeutics that prevent various diseases of aging.	Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
Founding Date	Founding Date 2009	Founding Date 2011	Founding Date 2009	Founding Date 2014
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations Warren, US HQ	Locations Houston, US HQ	Locations South San Francisco, US HQ	Locations San Diego, US HQ
Employees	Employees 1715% decrease	Employees 2	Employees 98	Employees 3939% increase
Valuation ($)	Valuation ($) 440.4 k	Valuation ($) 2.4 m	Valuation ($) 23.6 m	Valuation ($) 2.2 b
Financial
Net income	Net income ($19.8m) (FY, 2022)	Net income N/A	Net income ($26m) (FY, 2024)	Net income ($5.9m) (FY, 2017)
Funding
Total funding raised	Total funding raised $ 80m	Total funding raised N/A	Total funding raised $ 210.6m	Total funding raised $ 79m